Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 208547
Company: AAA USA INC
Company: AAA USA INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| NETSPOT | GALLIUM DOTATATE GA-68 | 2.1-5.5mCi/ML | POWDER;INTRAVENOUS | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/01/2016 | ORIG-1 | Approval | Type 1 - New Molecular Entity | PRIORITY; Orphan |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208547s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/208547Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208547Orig1s000TOC.html https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208547Orig1s000SumR.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 10/26/2023 | SUPPL-27 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208547s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208547Orig1s027ltr.pdf | |
| 12/22/2021 | SUPPL-24 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208547Orig1s024ltr.pdf | |
| 06/22/2021 | SUPPL-22 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s020s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208547Orig1s020, s022ltr.pdf | |
| 06/22/2021 | SUPPL-20 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s020s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208547Orig1s020, s022ltr.pdf | |
| 08/09/2018 | SUPPL-13 | Labeling-Package Insert |
Label is not available on this site. |
||
| 09/27/2018 | SUPPL-12 | Labeling-Package Insert |
Label is not available on this site. |
||
| 04/12/2018 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208547s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208547Orig1s011ltr.pdf | |
| 01/20/2017 | SUPPL-4 | Manufacturing (CMC) |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208547s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208547Orig1s004ltr.pdf | |
| 10/31/2016 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 09/02/2016 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208547s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/208547Orig1s002ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 10/26/2023 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208547s027lbl.pdf | |
| 10/26/2023 | SUPPL-27 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208547s027lbl.pdf | |
| 12/22/2021 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s024lbl.pdf | |
| 06/22/2021 | SUPPL-22 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s020s022lbl.pdf | |
| 06/22/2021 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s020s022lbl.pdf | |
| 04/12/2018 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208547s011lbl.pdf | |
| 01/20/2017 | SUPPL-4 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208547s004lbl.pdf |
| 09/02/2016 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208547s002lbl.pdf | |
| 06/01/2016 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208547s000lbl.pdf |